In the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease, minocycline reduced MPP+ induced glial iNOS expression, which was most likely due to an inhibition of p38 MAPK phosphorylation [19]. Here, NOS2 is linked to Parkinson disease.